Cardiomyopathy epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 12: Line 12:


==References==
==References==
{{Reflist|2}}
{{Richard P, Charron P, Carrier L, et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 2003; 107:2227.}}


[[Category:Needs content]]
[[Category:Needs content]]
Line 23: Line 23:
{{WH}}
{{WH}}
{{WS}}
{{WS}}
*Incidence and prevalence differ based on cause.
*# Richard P, Charron P, Carrier L, et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 2003; 107:2227.
 
*The incidence of DCM has been estimated to be 5-8 cases per 100,000 population, with a prevalence of 36 per 100,000. This could be explained by the incomplete disease expression, which goes unrecognized.
 
*The prevalence of HCM in the absence of aortic valve disease or systemic hypertension is at least 1:500 of the adult population.
 
*RCM is much less common than either DCM or HCM in the developed world, but is a frequent cause of death in the tropical countries, primarily because of the high incidence of endomyocardial fibrosis in those regions.

Revision as of 03:03, 16 December 2018

Cardiomyopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cardiomyopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Guidelines

2023 ESC Guideline Recommendations

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy

Case Studies

Case #1

Cardiomyopathy epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cardiomyopathy epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cardiomyopathy epidemiology and demographics

CDC on Cardiomyopathy epidemiology and demographics

Cardiomyopathy epidemiology and demographics in the news

Blogs on Cardiomyopathy epidemiology and demographics

Directions to Hospitals Treating Cardiomyopathy

Risk calculators and risk factors for Cardiomyopathy epidemiology and demographics

  • Incidence and prevalence differ based on cause.
  • The incidence of DCM has been estimated to be 5-8 cases per 100,000 population, with a prevalence of 36 per 100,000. This could be explained by the incomplete disease expression, which goes unrecognized.
  • The prevalence of HCM in the absence of aortic valve disease or systemic hypertension is at least 1:500 of the adult population.
  • RCM is much less common than either DCM or HCM in the developed world, but is a frequent cause of death in the tropical countries, primarily because of the high incidence of endomyocardial fibrosis in those regions.

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

References

Template:Richard P, Charron P, Carrier L, et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 2003; 107:2227.

Template:WH Template:WS

    1. Richard P, Charron P, Carrier L, et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 2003; 107:2227.